Furthermore, the suppressive activity of CD8+ Treg in vivo has been shown to be important in regulating normal immune function and preventing inflammatory disease in humans, including inflammatory bowel disease, autoimmune diabetes, multiple sclerosis, and GVHD (167–169). This evidence concerns the gene CD8A and graft versus host disease.